NT1 evaluated the clinical effectiveness of a new therapy at ICER, involving Foluso Agboola, Senior VP of Research.
1 report, 1 independent
Updated Aug 11
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
NT1 evaluated the clinical effectiveness of a new therapy at ICER, involving Foluso Agboola, Senior VP of Research.